Medical Marijuana Market to Experience Blatant Growth at 35.4% of CAGR during the Forecast Period 2019-2023

According to Market Research Future, the Global Medical Marijuana Market to provide readers with a clear view of the market’s likely growth trajectory over the coming years. The report utilizes historical trends of the Global Medical Marijuana Market and present statistics to derive.

Pune, India - February 12, 2019 /MarketersMedia/ —

Medical Marijuana Market - Synopsis

Global Medical Marijuana Market is forecasted to expand remarkably at a CAGR of over 35.4% during the forecast period of 2018-2023. Medical marijuana or medical cannabis is the unprocessed marijuana plant or its extracts that are used to treat the symptoms of various diseases and other medical conditions.

Marijuana consists of chemical components cannabinoids,  which can be used as medicine to treat the symptoms caused by illness. Medical marijuana plant or extract of the plant is used for the treatment. The increasing number of chronic diseases, rising acceptance of medical marijuana in healthcare and increasing research and development activities are the major factors driving the growth of the global medical marijuana market. Additionally, increasing U.S. Food and Drug Administration (FDA) approvals for drugs containing cannabinoids are contributing to the growth of the market. For instance, in June 2018, U.S. Food and Drug Administration (FDA) has approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of epilepsy.

Request Sample Copy at https://www.marketresearchfuture.com/sample_request/6470

The stringent regulatory environment for product approval, increasing use of marijuana for recreational use and side effects caused by long-term use of marijuana are likely to hinder market growth during the forecast period.

Top Players:

The key players profiled by MRFR that are operating in the global medical marijuana market are Canopy Growth, Aurora Cannabis, Inc., Cannabis Sativa, Inc, GW Pharmaceuticals plc, United Cannabis, MGC Pharma, Aphria, Inc., Tilray, Emerald Health Therapeutics [Canada] Inc., GBSciences, Inc., CanniMed Ltd., Medical Marijuana, Inc, Cara Therapeutics, and Greengro Technologies.

Segmentation:

The global medical marijuana market has been segmented on the basis of application, route of administration and distribution channel.

On the basis of application, the market has been classified as Alzheimer’s disease, cancer, mental health conditions, multiple sclerosis, muscle spasms, glaucoma, and human immunodeficiency virus, acquired immunodeficiency syndrome (HIV/AIDS). Mental health conditions are differentiated into schizophrenia and posttraumatic stress disorder (PTSD).

The route of administration segment has been further divided into oral, topical, inhalation and sublingual. The topical segment has been classified into ointments, lotions, creams, gels, and poultice.

The market, by distribution channel, has been segmented into dispensaries and online platforms.

Industry Updates:

In January 2019, it has been announced by the Arkansans Department of Health that the patients who are approved for purchasing medical; marijuana will receive patient cards by February 2019.

In January 2019, it has been announced that within next few days residents in Ohio will be able to purchase marijuana for medical purposes.

In January 2019, Trulieve, Florida's largest and first medical marijuana provider, has signed a deal to bring high-end edible marijuana products to Florida and will soon be made available for the registered medical marijuana patients in the form of cannabis chocolates, granola bars, honey, fruit leather, olive oil and more.

Medical Marijuana Market - Regional Analysis:

The market in the Americas is expected to dominate the global medical marijuana market during the forecast period owing to the increasing prevalence of chronic diseases, increasing number of cannabinoid drug approvals by regulatory authorities, and increasing expenditure on research and development of medical marijuana. The European market is expected to be the second-largest due to the favorable policies implemented by government and regulatory authorities and increasing applications of marijuana in healthcare. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to the increasing number of mental disorders and increasing expenditure on healthcare research and development. The market in the Middle East & Africa is likely to account for the smallest share of the global medical marijuana market. The market growth in this region can be attributed to the rising acceptance of medical marijuana in the treatment of illness and favorable government policies.

Browse Complete 85 Pages Premium Research Report Enabled with Respective 30+ Tables and Figures at https://www.marketresearchfuture.com/reports/medical-marijuana-market-6470

Some Points From TOC of Medical Marijuana Market Research Report – Forecast to 2023:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

TOC CONTINUED…!

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
Phone: 6468459312
Website: https://www.marketresearchfuture.com/reports/medical-marijuana-market-6470

Source URL: https://marketersmedia.com/medical-marijuana-market-to-experience-blatant-growth-at-354-of-cagr-during-the-forecast-period-2019-2023/481621

Source: MarketersMedia

Release ID: 481621

Latest News

Myanmar sentences 2 to death in killing of Suu Kyi aide

Feb 15, 2019

YANGON, Myanmar — A court in Myanmar sentenced two men to death on Friday for the killing of a prominent Muslim lawyer who was a close adviser to the country's leader, Aung San Suu Kyi. The Yangon Northern District Court found Kyi Lin guilty of premeditated murder and illegal weapons possession in the Jan. 29, 2017, shooting of Ko Ni at Yangon's airport. It also sentenced to death another man for helping to plan the killing, and gave prison sentences to two other men it said were also involved in the crime. A fifth suspect accused of being the mastermind...

Thai princess' political bid sunk by her brother, the king

Feb 15, 2019

BANGKOK — Thailand's chaotic politics took two astonishing turns Friday when the sister of the king made a historic bid to become prime minister, only to have him shut down her effort as "inappropriate" because it violated tradition and the constitution, which keep the monarchy from getting involved in politics. The royal order from King Maha Vajiralongkorn was read on national television late Friday night, effectively scuttling the move by his older sister, Princess Ubolratana Mahidol, to become a candidate for the prime minister's office after parliamentary elections scheduled for March 24. It was the latest event to roil Thailand,...

Thai princess finds tumult in politics, like life

Feb 15, 2019

BANGKOK — Princess Ubolratana Mahidol, the first child of Thailand's beloved late king, has always been a bit of a rebel, and on Friday she shook Thai society by becoming the first member of the royal family to say she would enter party politics. But hours later, her younger brother, King Maha Vajiralongkorn, commanded her to halt her bid to become prime minister, saying in an order read on television that no member of the royal family should be involved in politics. It wasn't the first unexpected turn in a somewhat turbulent life. Ubolratana, 67, was born into royalty but...

Philippine official: Abu Sayyaf harboring suicide bomber

Feb 15, 2019

MANILA, Philippines — An Abu Sayyaf militant leader accused of plotting a recent suicide attack in a Roman Catholic cathedral in the southern Philippines may be harboring a foreign would-be suicide bomber in his jungle base, a senior official said Thursday. Interior Secretary Eduardo Ano said Abu Sayyaf commander Hatib Hajan Sawadjaan, who allegedly plotted the Jan. 27 attack at Our Lady of Mount Carmel Cathedral on Jolo island that killed 23 people, was also behind a suicide attack last year that killed 11 people in nearby Basilan province. Sawadjaan's goal was to assert his new role as Islamic State...

Philippine police: 5 church bombing suspects in custody

Feb 15, 2019

MANILA, Philippines — Five suspected Abu Sayyaf militants accused of involvement in a deadly suicide attack at a Roman Catholic cathedral in the southern Philippines have surrendered to authorities, the national police chief said Monday amid renewed terrorism fears. Complaints for murder and attempted murder were filed against the five, as well as several other suspected Abu Sayyaf fighters who remain at large, for their alleged role in the Jan. 27 attack at Our Lady of Mount Carmel Cathedral in Sulu province's Jolo town which killed 23 people and wounded nearly 100 others. Before the bombing, the detained suspects escorted...

Sign up now!